Abstract
Cerebral cavernous malformations (CCM) are common hamartous dysplasias characterized by abnormally dilated vascular channels. CCM mostly occur sporadically, and multiple occurrence of CCM is highly suggestive of a genetic origin of the disorder. Typical clinical symptoms are seizures, hemorrhages, focal neurological deficits, and headaches. Three genes have so far been described that are responsible for most cases of familial CCM and more than half of the sporadic cases with multiple CCM (CCM1–3). The coincidence of CCM and other vascular anomalies has been described before. The present review discusses the association of CCM with mesenchymal anomalies, with special emphasis on the possible common pathogenetic pathway for CCM and atrial myxomas. An illustrative case is presented in which CCM occurred together with different dysplasias (multiple CCM, liver cavernoma, and cardiac atrial myxoma), which are all thought to arise from abnormal mesenchymal cell differentiation processes.
Similar content being viewed by others
References
Atherton DJ, Pitcher DW, Wells RS, MacDonald DM (1980) A syndrome of various cutaneous pigmented lesions, myxoid neurofibromata and atrial myxoma: the NAME syndrome. Br J Dermatol 103:421–429
Awad IA, Robinson JR Jr, Mohanty S, Estes ML (1993) Mixed vascular malformations of the brain: clinical and pathogenetic considerations. Neurosurgery 33:179–188
Awad I, Jabbour P (2006) Cerebral cavernous malformations and epilepsy. Neurosurg Focus 21:e7
Basson CT, Aretz HT (2002) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 11–2002. A 27-year-old woman with two intracardiac masses and a history of endocrinopathy. N Engl J Med 346:1152–1158
Bertalanffy H, Benes L, Miyazawa T, Alberti O, Siegel AM, Sure U (2002) Cerebral cavernomas in the adult. Review of the literature and analysis of 72 surgically treated patients. Neusurg Rev 25:1–53
Burke AP, Virmani R (1993) Cardiac myxoma. A clinicopathologic study. Am J Clin Pathol 100:671–680
Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL (1985) The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine 64:270–283
Casey M, Vaughan CJ, He J, Hatcher CJ, Winter JM, Weremowicz S, Montgomery K, Kucherlapati R, Morton CC, Basson CT (2000) Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. J Clin Invest 106:R31–R38
Clatterbuck RE, Eberhart CG, Crain BJ, Rigamonti D (2001) Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry 71:188–192
Del Curling O Jr, Kelly DL Jr, Elster AD, Craven TE (1991) An analysis of the natural history of cavernous angiomas. J Neurosurg 75:702–8
Denier C, Goutagny S, Labauge P, Krivosic V, Arnoult M, Cousin A, Benabid AL, Comoy J, Frerebeau P, Gilbert B, Houtteville JP, Jan M, Lapierre F, Loiseau H, Menei P, Mercier P, Moreau JJ, Nivelon-Chevallier A, Parker F, Redondo AM, Scarabin JM, Tremoulet M, Zerah M, Maciazek J, Tournier-Lasserve E (2004) Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet 74:326–337
Dobyns WB, Michels VV, Groover RV (1987) Familial cavernous malformations of the CNS and retina. Ann Neurol 21:578–583
Drigo P, Battistella PA, Mammi I (1995) Familial cerebral, hepatic, and retinal cavernous angiomas. Child’s Nerv Syst 11:65
Farah MG (1975) Familial atrial myxoma. Ann Intern Med 83:358–360
Feiz-Erfan I, Zabramski JM, Herrmann LL, Coons SW (2006) Cavernous malformation within a schwannoma: review of the literature and hypothesis of a common genetic etiology. Acta Neurochir 148:647–652
Felbor U, Sure U, Grimm T, Bertalanffy H (2006) Genetics of cerebral cavernous angioma. Zentralbl Neurochir 67:110–116
Felbor U, Gaetzner S, Verlaan DJ, Vijzelaar R, Rouleau GA, Siegel AM (2007) Large germline deletions and duplication in isolated cerebral cavernous malformation patients. Neurogenetics 8:149–153
Ferrans VJ, Roberts WC (1973) Structural features of cardiac myxomas. Histology, histochemistry, and electron microscopy. Hum Pathol 4:111–146
Fritschi JA, Reulen HJ, Spetzler RF, Zabramski JM (1994) Cavernous malformations of the brain stem. A review of 139 cases. Acta Neurochir 130:35–46
Fukushima T, Ohkawa M, Tomonaga M (1986) Multiple and familial cavernous angiomas in the brain and extremities–case report (in Japanese). No Shinkei Geka 14:423–428
Gaetzner S, Stahl S, Surucu O, Schaafhausen A, Halliger-Keller B, Bertalanffy H, Sure U, Felbor U (2007) CCM1 gene deletion identified by MLPA in cerebral cavernous malformation. Neurosurg Rev 30:155–159
Garcia-Moreno JM, Gamero MA, Lucas M, Garcia-Bravo B, Rodriguez L, Izquierdo G (1998) Familial cerebral cavernomatosis associated with cutaneous angiomas (in Spanish). Rev Neurol 27:484–490
Gault J, Shenkar R, Recksiek P, Awad IA (2005) Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion. Stroke 36:872–874
Giombini S, Morello G (1978) cavernous angiomas of the brain: account of fourteen personal cases and review of the literature. Acta Neurochir 40:61–82
Janssens J, Boland B, Draguet AP, Van Beers BE, Godfraind C, Rahier J, Lerut J, Geubel A (1999) Diffuse liver angiosarcoma and cerebral cavernous angiomas in a young patient. Acta Gastroenterol Belg 62:446–449
Kigawa I, Fukuda S, Marat D, Tanaka J, Ikeda S, Okiyama M, Horii T, Suma H, Wanibuchi Y (1996) A case of familial cardiac myxoma (in Japanese). Kyobu Geka 49:323–326
Kimura T, Sako K, Ishizaki T, Hashizume K, Yonemasu Y, Hamada O (1996) Familial multiple cavernous angioma in the brain and spinal cord (in Japanese). No To Shinkei 48:955–959
Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS, Stratakis CA (2000) Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 26:89–92
Knepper LE, Biller J, Adams HP Jr, Bruno A (1988) Neurologic manifestations of atrial myxoma. A 12-year experience and review. Stroke 19:1435–1440
Kondziolka D, Lunsford LD, Kestle JR (1995) The natural history of cerebral cavernous malformations. J Neurosurg 83:820–824
Kraemer DL, Awad IA (1994) Vascular malformations and epilepsy: clinical considerations and basic mechanisms. Epilepsia 35(Suppl 6):S30–S43
Labauge P, Laberge S, Brunereau L, Levy C, Tournier-Lasserve E (1998) Hereditary cerebral cavernous angiomas: clinical and genetic features in 57 French families. Societe Francaise de Neurochirurgie. Lancet 12:1892–1897
Labauge P, Enjolras O, Bonerandi JJ, Laberge S, Dandurand M, Joujoux JM, Tournier-Lasserve E (1999) An association between autosomal dominant cerebral cavernomas and a distinctive hyperkeratotis cutaneous vascular malformation in 4 families. Ann Neurol 45:250–254
Labauge P, Brunereau L, Levy C, Laberge S, Houtteville JP (2000) The natural history of familial cerebral cavernomas: a retrospective MRI study of 40 patients. Neuroradiology 42:327–332
Labauge P, Denier C, Bergametti F, Tournier-Lasserve E (2007) Genetics of cavernous angiomas. Lancet Neurol 6:237–244
Laurans MS, DiLuna ML, Shin D, Niazi F, Voorhees JR, Nelson-Williams C, Johnson EW, Siegel AM, Steinberg GK, Berg MJ, Scott RM, Tedeschi G, Enevoldson TP, Anson J, Rouleau GA, Ogilvy C, Awad IA, Lifton RP, Gunel M (2003) Mutational analysis of 206 families with cavernous malformations. J Neurosurg 99:38–43
Lee KS, Spetzler RF (1990) Spinal cord cavernous malformation in a patient with familial intracranial cavernous malformations. Neurosurgery 26:877–880
Lehnhardt FG, von Smekal U, Ruckriem B, Stenzel W, Neveling M, Heiss WD, Jacobs AH (2005) Value of gradient-echo magnetic resonance imaging in the diagnosis of familial cerebral cavernous malformation. Arch Neurol 62:653–658
Mably JD, Chuang LP, Serluca FC, Mohideen MA, Chen JN, Fishman MC (2006) Santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish. Development 133:3139–3146
Mao Y, Zhao Y, Zhou LF, Huang CX, Shou XF, Gong JL, Lawton MT, Yang GY (2005) A novel gene mutation (1292 deletion) in a Chinese family with cerebral cavernous malformations. Neurosurgery 56:1149–1153
Marra A, Dario A, Svamoni C, Dorizzi A (1993) Intracranial aneurysm associated with cerebral cavernous angioma. Case report. J Neurosurg Sci 37:25–27
Moriarity JL, Clatterbuck RE, Rigamonti D (1999) The natural history of cavernous malformations. Neurosurg Clin N Am 10:411–417
Otten P, Pizzolato GP, Rilliet B, Berney J (1989) 131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies. Neurochirurgie 35:82–83
Pascual-Castroviejo I (1985) The association of extracranial and intracranial vascular malformations in children. Can J Neurol Sci 12:139–148
Reynen K (1995) Cardiac myxomas. N Engl J Med 333:1610–1617
Revencu N, Vikkula M (2006) Cerebral cavernous malformation: new molecular and clinical insights. J Med Genet 43:716–721
Rhodes AR, Silverman RA, Harrist TJ, Perez-Atayde AR (1984) Mucocutaneous lentigines, cardiomucocutaneous myxomas, and multiple blue nevi: the “LAMB” syndrome. J Am Acad Dermatol 10:72–82
Rigamonti D, Johnson PC, Spetzler RF, Hadley MN, Drayer BP (1991) Cavernous malformations and capillary telangiectasia: a spectrum within a single pathological entity. Neurosurgery 28:60–64
Roeltgen DP, Weimer GR, Patterson LF (1981) Delayed neurologic complications of left atrial myxoma. Neurology 31:8–13
Sabolek M, Bachus-Banaschak K, Bachus R, Arnold G, Storch A (2005) Multiple cerebral aneurysms as delayed complication of left cardiac myxoma: a case report and review. Acta Neurol Scand 111:345–350
Samaratunga H, Searle J, Cominos D, Le Fevre I (1994) Cerebral metastasis of an atrial myxoma mimicking an epithelioid hemangioendothelioma. Am J Surg Pathol 18:107–111
Schwartz AC, Weaver RG, Bloomfield R, Tyler ME (1984) Cavernous haemangioma of the retina, cutaneous angiomas and intravascular lesion by computed tomography and nuclear magnetic resonance imaging. Am J Ophthalmol 98:483–487
Siegel AM, Bertalanffy H, Dichgans JJ, Elger CE, Hopf H, Hopf N, Keidel M, Kleider A, Nowak G, Pfeiffer RA, Schramm J, Spuck S, Stefan H, Sure U, Baumann CR, Rouleau GA, Verlaan DJ, Andermann E, Andermann F (2005) Familial cavernous malformations of the central nervous system. A clinical and genetic study of 15 German families (in German). Nervenarzt 76:175–180
Singh SD, Lansing AM (1996) Familial cardiac myxoma—a comprehensive review of reported cases. J Ky Med Assoc 94:96–104
Stacey RJ, Findlay GF, Foy PM, Jeffreys RV (1999) Cavernomas in the central nervous system and the relevance of multiple intracranial lesions in the familial form of this disease. J Neurol Neurosurg Psychiatry 66:117
Steinmetz EF, Calanchini PR, Aguilar MJ (1973) Left atrial myxoma as a neurological problem: a case report and review. Stroke 4:451–458
Vaughan CJ, Veugelers M, Basson CT (2001) Tumors and the heart: molecular genetic advances. Curr Opin Cardiol 16:195–200
Vishteh AG, Zabramski JM, Spetzler RF (1999) Patients with spinal cord cavernous malformations are at an increased risk for multiple neuraxis cavernous malformations. Neurosurgery 45:30–32
Wada A, Kanda T, Hayashi R, Imai S, Suzuki T, Murata K (1993) Cardiac myxoma metastasized to the brain: potential role of endogenous interleukin-6. Cardiology 83:208–211
Wang QK (2005) Update on the molecular genetics of vascular anomalies. Lymphat Res Biol 3:226–233
Wong JH, Awad IA, Kim JH (2000) Ultrastructural pathological features of cerebrovascular malformations: a preliminary report. Neurosurgery 46:1454–1459
Zabramski JM, Wascher TM, Spetzler RF, Johnson B, Golfinos J, Drayer BP, Brown B, Rigamonti D, Brown G (1994) The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg 80:422–432
Zawistowski JS, Stalheim L, Uhlik MT, Abell AN, Ancrile BB, Johnson GL, Marchuk DA (2005) CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum Mol Genet 14:2521–2531
Acknowledgements
The authors want to thank Ute Felbor, M.D., Ph.D., from the Institute of Human Genetics, University of Würzburg, for the genetic analysis of the presented case and helpful comments.
Author information
Authors and Affiliations
Corresponding author
Additional information
Comments
Ulrich Sure, Marburg, Germany
Ardeshiri et al. present a unique case of cerebral cavernoma associated with a cardial myxoma. The paper represents a well-written case report in which possible genetic alterations within the CCM1–3 genes were also extensively studied. The authors nicely review the current literature on extracranial mesenchymal anomalies associated with cerebral cavernomas that have been reported so far. This data is nicely summarized in Table 1 and shows that extracranial vascular malformations associated with cavernomas seem to be more likely than nonvascular extracranial lesions. Since the time that I was aware of possible cutaneous manifestation in CCM disease, I discovered three individuals with such a phenotype in our institution. All these were patients suffering from multiple cavernomas. Therefore, these were more likely to bear a CCM-related genetic alteration and are currently studied for mutations. The present case also harbored multiple lesions but unfortunately was not successfully diagnosed for a specific CCM mutation.
In summary, I think this is an important paper because (1) it shows that we should look at associated mesenchymal pathologies in patients with multiple cavernomas and (2) we should offer genetic testing to these individuals to inform our patients about their possible risk to pass on the same disease to the next generation, more likely even at a younger age (1).
Reference
1. Siegel AM, Andermann E, Badhwar A, Rouleau GA, Wolford GL, Andermann F, Hess K (1998) Anticipation in familial cavernous angioma: a study of 52 families from International Familial Cavernous Angioma Study. IFCAS Group. Lancet 352:1676–1677
Rights and permissions
About this article
Cite this article
Ardeshiri, A., Ardeshiri, A., Beiras-Fernandez, A. et al. Multiple cerebral cavernous malformations associated with extracranial mesenchymal anomalies. Neurosurg Rev 31, 11–18 (2008). https://doi.org/10.1007/s10143-007-0111-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10143-007-0111-7